Thomas M Demarco, MD in Salisbury, MD - Medicare Urology

Thomas M Demarco, MD is a medicare enrolled "Urology" physician in Salisbury, Maryland. His current practice location is 100 E Carroll St, Salisbury, Maryland. You can reach out to his office (for appointments etc.) via phone at (410) 543-7252.

Thomas M Demarco is licensed to practice in Maryland (license number D27820) and he also participates in the medicare program. He does not accept medicare assignments directly but he may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. His NPI Number is 1194786160.

Contact Information

	Thomas M Demarco, MD
	100 E Carroll St, Salisbury, MD 21801-5422
	(410) 543-7252
	Not Available

Physician's Profile

Full Name	Thomas M Demarco
Gender	Male
Speciality	Urology
Location	100 E Carroll St, Salisbury, Maryland
Accepts Medicare Assignments	Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.

NPI Data:

NPI Number: 1194786160
Provider Enumeration Date: 03/30/2006
Last Update Date: 12/18/2018

Medicare PECOS Information:

PECOS PAC ID: 9739113374
Enrollment ID: I20100924000391

Medical Identifiers

Medical identifiers for Thomas M Demarco such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1194786160	NPI	-	NPPES
309751000	Medicaid	MD

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208800000X	Urology	D27820 (Maryland)	Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Thomas M Demarco allows following entities to bill medicare on his behalf.

Entity Name	Tidalhealth Peninsula Regional, Inc.
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1184832040 PECOS PAC ID: 3072509702 Enrollment ID: O20040420001571

News Archive

SutroVax completes $22 million Series A financing

SutroVax, a recently established biopharmaceutical vaccine company, today announced the completion of a $22 million Series A financing. SutroVax is developing vaccines for infectious disease targets, with an initial emphasis on best-in-class conjugate vaccines, using an exclusive license to Sutro Biopharma's Xpress CF and Xpress CF+ platforms for cell free protein synthesis and site-specific conjugation respectively.

Pulmatrix reports positive results from initial PUR0200 Phase IB clinical study in COPD

Pulmatrix today announced the successful completion and positive results of the first part of a two-part Phase IB clinical study in chronic obstructive pulmonary disease (COPD) patients with their lead clinical candidate PUR0200.

Scientists mimic dyskeratosis congenita through study of undifferentiated iPS cells

A rare genetic disease called dyskeratosis congenita, caused by the rapid shortening of telomeres, can be mimicked through the study of undifferentiated induced pluripotent stem cells, according to new findings from the Stanford University School of Medicine.

Okayama University researchers uncover potential new therapeutic target for invasive bladder cancer

Researchers at Okayama University have uncovered a potential new therapeutic target for invasive bladder cancer. The GTP hydrolysing enzyme (GTPase), called Dynamin2, facilitates the rapid invasion of cancer into surrounding tissues; inhibiting its activity could limit the progression of bladder cancer.

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Thomas M Demarco is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Thomas M Demarco, MD 100 E Carroll St, Salisbury, MD 21801-5422 Ph: (800) 749-5191	Thomas M Demarco, MD 100 E Carroll St, Salisbury, MD 21801-5422 Ph: (410) 543-7252

News Archive

SutroVax completes $22 million Series A financing

Pulmatrix reports positive results from initial PUR0200 Phase IB clinical study in COPD

Scientists mimic dyskeratosis congenita through study of undifferentiated iPS cells

Okayama University researchers uncover potential new therapeutic target for invasive bladder cancer

Urology Doctors in Salisbury, MD

Dr. Alyssa Kay Gracely, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 1111 Mount Hermon Rd, Salisbury, MD 21804 Phone: 866-953-3111
Mark T Edney, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 1342 South Division Street, Unit 401 Peninsula Urology Associates Pa, Salisbury, MD 21084 Phone: 410-546-2133 Fax: 210-548-3361
Harold I Genvert, MD Urology Medicare: Medicare Enrolled Practice Location: 1342 South Division Street, Unit 401, Salisbury, MD 21084 Phone: 410-546-2133 Fax: 410-548-3361

Thomas M Demarco, MD - Medicare Urology in Salisbury, MD

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medicare Reassignments

SutroVax completes $22 million Series A financing

Pulmatrix reports positive results from initial PUR0200 Phase IB clinical study in COPD

Scientists mimic dyskeratosis congenita through study of undifferentiated iPS cells

Okayama University researchers uncover potential new therapeutic target for invasive bladder cancer

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

SutroVax completes $22 million Series A financing

Pulmatrix reports positive results from initial PUR0200 Phase IB clinical study in COPD

Scientists mimic dyskeratosis congenita through study of undifferentiated iPS cells

Okayama University researchers uncover potential new therapeutic target for invasive bladder cancer

Urology Doctors in Salisbury, MD